Physician profile
Robert B Andres
NPI 1043653686
$1,264.18
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.16 · 2020: $13.02 · 2022: $88.41 · 2023: $401 · 2024: $573 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $239.99 | 2024 | Airsupra |
| Pfizer INC. | $199.55 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $189.99 | 2022-2024 | Xarelto |
| Paratek Pharmaceuticals, INC. | $149.83 | 2022-2024 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.90 | 2023-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.70 | 2024 | Jardiance |
| Ceribell, INC. | $64.62 | 2025 | Pocket Eeg Device |
| Novartis Pharmaceuticals Corporation | $53.29 | 2019-2024 | |
| Inari Medical, INC. | $44.26 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $32.29 | 2023-2024 | Veklury |
| Stryker Corporation | $28.77 | 2025 | Flowtriever |
| Melinta Therapeutics, LLC | $18.86 | 2023 | Rezzayo, Orbactiv, Kimyrsa |
| Abbott Laboratories | $17.55 | 2024 | Jot Dx |
| Baxter Healthcare | $16.58 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Andres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.